Your browser doesn't support javascript.
loading
Glucokinase activators in diabetes management.
Coghlan, Matthew; Leighton, Brendan.
Affiliation
  • Coghlan M; AstraZeneca Pharmaceuticals, Diabetes and Obesity Drug Discovery, Cardiovascular and Gastrointestinal Research Area, Mereside, Alderley Park, Macclesfi eld SK10 4TG, UK. matthew.coghlan@astrazeneca.com
Expert Opin Investig Drugs ; 17(2): 145-67, 2008 Feb.
Article in En | MEDLINE | ID: mdl-18230050
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Glucokinase / Hypoglycemic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Expert Opin Investig Drugs Journal subject: TERAPIA POR MEDICAMENTOS Year: 2008 Document type: Article Affiliation country: United kingdom Country of publication: United kingdom